University of Kentucky

UKnowledge
Theses and Dissertations--Psychology

Psychology

2011

EFFECTS OF A SHORT-TERM MINDFULNESS INTERVENTION ON
DEPRESSION AND IMMUNE FUNCTION
Erin C. Walsh
University of Kentucky, edubwalsh@gmail.com

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Walsh, Erin C., "EFFECTS OF A SHORT-TERM MINDFULNESS INTERVENTION ON DEPRESSION AND
IMMUNE FUNCTION" (2011). Theses and Dissertations--Psychology. 2.
https://uknowledge.uky.edu/psychology_etds/2

This Doctoral Dissertation is brought to you for free and open access by the Psychology at UKnowledge. It has
been accepted for inclusion in Theses and Dissertations--Psychology by an authorized administrator of
UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.

STUDENT AGREEMENT:
I represent that my thesis or dissertation and abstract are my original work. Proper attribution
has been given to all outside sources. I understand that I am solely responsible for obtaining
any needed copyright permissions. I have obtained and attached hereto needed written
permission statements(s) from the owner(s) of each third-party copyrighted matter to be
included in my work, allowing electronic distribution (if such use is not permitted by the fair use
doctrine).
I hereby grant to The University of Kentucky and its agents the non-exclusive license to archive
and make accessible my work in whole or in part in all forms of media, now or hereafter known.
I agree that the document mentioned above may be made available immediately for worldwide
access unless a preapproved embargo applies.
I retain all other ownership rights to the copyright of my work. I also retain the right to use in
future works (such as articles or books) all or part of my work. I understand that I am free to
register the copyright to my work.
REVIEW, APPROVAL AND ACCEPTANCE
The document mentioned above has been reviewed and accepted by the student’s advisor, on
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of
the program; we verify that this is the final, approved version of the student’s dissertation
including all changes required by the advisory committee. The undersigned agree to abide by
the statements above.
Erin C. Walsh, Student
Dr. Ruth A. Baer, Major Professor
David T.R. Berry, Director of Graduate Studies

EFFECTS OF A SHORT-TERM MINDFULNESS INTERVENTION ON
DEPRESSION AND IMMUNE FUNCTION

_________________________________________________
DISSERTATION
_________________________________________________
A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy in the
College of Arts and Sciences
at the University of Kentucky

By
Erin C. Walsh
Lexington, Kentucky
Director: Dr. Ruth A. Baer, Professor of Psychology
Lexington, Kentucky
2011
Copyright © Erin Celine Walsh 2011

ABSTRACT OF DISSERTATION

EFFECTS OF A SHORT-TERM MINDFULNESS INTERVENTION ON
DEPRESSION AND IMMUNE FUNCTION
Pro-inflammatory cytokines have been implicated in the pathophysiology and
maintenance of depression. This study investigated the effects of a short mindfulness
intervention on pro-inflammatory correlates of depression (IL-6 and TNF-α) and selfreported psychological health. Sixty-four college females were assigned to a four-week
mindfulness training group or a contact-control group. Cytokines and psychological
health were assessed at baseline, post-treatment, and 3-month follow-up (mindfulness
group only). IL-6 and TNF-α significantly decreased from baseline to post-treatment in
the mindfulness group only; these changes were sustained at 3-month follow-up. No
between-group differences in psychological health emerged. Although reductions in proinflammatory cytokines in the mindfulness condition were not attributable to
psychological changes, they may serve to protect against the development of future
depressive episodes.
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Section One: Introduction
Depression affects approximately 20.9 million US adults (9.5%) each year
(NIMH, 2008). Individuals with depression are impaired in many domains of functioning
and are at higher risk for disease morbidity (Cuijpers & Smit, 2002; Rudisch &
Nemeroff, 2003). Although depressive episodes can be effectively treated and may
resolve without treatment, the high risk of relapse associated with unipolar major
depression necessitates the identification of effective prevention and relapse-prevention
strategies (Gotlib & Hammen, 2002). Adults who have experienced one major depressive
episode have a 60% likelihood of recurrence, and this risk increases with each episode,
such that those who have a history of three episodes have a 90% likelihood of
experiencing a fourth (DSM-IV-TR, 2000).
Associations between Depression and Innate Immunity
Nonspecific immune, behavioral, and physiological changes occur with the
presence of infection or inflammation (Dantzer, 2001; 2006). Such illness responses
include fever, fatigue, difficulties with concentration, lack of interest in surroundings,
reduced food intake, and behavioral disengagement (Dantzer, 2001; 2006; Kemeny,
2006). Collectively, these symptoms are referred to as “sickness behavior”. Sickness
behavior is considered a normal and adaptive response to acute immune threats (Dantzer
2001; 2006; Dantzer et al., 2006). It enhances survival by allowing the organism to
conserve energy and disengage from situations or environments that are potentially
harmful, thus promoting numerous healing and restorative processes (Kemeny, 2006).
Although sickness behavior is regarded as an adaptive mechanism in particular contexts,
it is also believed to contribute to the pathophysiology and maintenance of depression
(Dantzer, 2001, 2006).
Sickness behavior is triggered by pro-inflammatory cytokines, including
interleukins (e.g. IL-1, IL-6), interferons, and Tumor Necrosis Factor-alpha (TNF-α)
(Dantzer, 2001, 2006; Dantzer et al., 2006). Pro-inflammatory cytokines are often
produced by innate immune cells (Dantzer, 2001; Dinan, 2008) and have been related to
depression in the following ways: 1) Increased levels of circulating pro-inflammatory
cytokines are observed in individuals with depressive symptomatology (Howren et al.,
2009; Zorrilla et al., 2001); 2) Individuals with an underlying inflammatory disease
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experience symptoms of depression, likely due to disease-related release of proinflammatory cytokines (Kemeney, 2006; Capuron et al., 2006); 3) Patients undergoing
immunotherapy to treat cancer report psychological and behavioral changes consistent
with depression upon short-term administration of a pro-inflammatory cytokine (Capuron
et al., 2002) - especially individuals identified as “at-risk” (Capuron & Ravaud, 1999), 4)
Animals injected with pro-inflammatory cytokines exhibit behavioral signs of sickness
(Dantzer et al., 2006), and 5) Administration of anti-depressants to animals reduces levels
of circulating pro-inflammatory cytokines and sickness behavior (Pollak & Yirmiya,
2002). Although this evidence is suggestive that pro-inflammatory cytokines cause
depression, the directionality of this relationship is much more complex. The positive
association between pro-inflammatory cytokines and depression is likely the result of a
bidirectional process, in which immune products alter depressive symptoms, and vice
versa (Howren et al., 2009). Finally, and most pertinent to human research on
depression, a recent meta-analysis shows that higher concentrations of IL-6 and TNF-α
are more likely to be found in depressed participants than other pro-inflammatory
markers (Dowlati et al., 2010).
Effects of Mindfulness-Based Practices on Psychological States and Functioning
Mindfulness is a form of self-regulation of attention that originates from Eastern
spiritual traditions and is conceptualized as nonjudgmentally bringing attention to internal
and external events that arise within the present moment (Kabat-Zinn, 1994). Sustained
practice of mindfulness is thought to enhance positive personal qualities, such as
awareness, insight, wisdom, and compassion, and to reduce suffering (Goldstein, 2002;
Kabat-Zinn, 2003). Although historically rooted in Buddhism, mindfulness has been
adopted in secular form as an intervention for numerous psychological and physical
ailments in Western settings (Baer, 2003).
One of the most cited programs in mindfulness training is mindfulness-based
stress reduction (MBSR), developed by Kabat-Zinn (1982, 1990). MBSR is typically
conducted in a group setting over the course of 8 weeks, with up to 30 members per
group and weekly sessions lasting 2.0 - 2.5 hours. Versions with fewer and shorter
sessions have been reported, with no loss of efficacy (Carmody & Baer, 2009). In
standard MBSR, patients are encouraged to practice mindfulness meditation exercises at
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home for 45 minutes per day, six days a week during the intervention. Several studies
have reported shorter practice times (20 minutes per day), again with no loss of efficacy
(Carmody & Baer, 2009). Patients in MBSR are taught to observe their experiences,
including uncomfortable or distressing thoughts and sensations, in a nonjudgmental, nonavoidant fashion. Practicing mindfulness is thought to increase patients' tolerance of
unpleasant physical, cognitive, and emotional states through processes of repeated
exposure or decentering (Baer, 2003; Keng, Smoski, & Robins, 2011). Mindfulness
practices taught in this program include hatha yoga, the body scan, sitting and walking
meditations, and activities for cultivating mindfulness in daily life (Baer, 2006).
Studies have shown mindfulness-based interventions to be efficacious for a
variety of disorders including depression (Baer, 2003; Kabat-Zinn, 2003). Self-reported
benefits include reductions in mood disturbance, anxiety, difficulties with emotion
regulation, and general psychological symptoms, and increases in psychological wellbeing (see Keng et al., 2011 for a review). Furthermore, mindfulness-based cognitive
therapy (MBCT), a program closely based on MBSR that integrates mindfulness
techniques with cognitive therapy, has demonstrated efficacy in the prevention of
depression relapse for a period of one year following treatment, with individuals who
have experienced three or more previous episodes (Teasdale et al., 2000; Segal, 2002; Ma
& Teasdale, 2004). Several studies have also shown that administering MBCT to acutely
depressed participants yields clinically significant improvements (Eisendrath et al., 2008;
Finucane & Mercer, 2006; Kenny & Williams, 2006; Kingston et al., 2007; Ree &
Craigee, 2007).
Effects of Mindfulness-Based Practices on Immunity
Investigations examining the effects of mindfulness practice on immune and
neuroendocrine function have yielded promising results. Davidson et al. (2003) reported
that participation in an 8-week MBSR program enhanced antibody titers to influenza
vaccination in a sample of healthy but stressed adults. Creswell et al. (2009) showed that
patients diagnosed with HIV did not exhibit declines in CD4+ T lymphocytes upon
completion of an 8-week MBSR intervention, whereas those in a control condition
showed the expected declines. Carlson et al. (2003) and Witek-Janusek et al. (2008)
found significant reductions in pro-inflammatory cytokines among cancer patients
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enrolled in an 8-week MBSR course, and these results were sustained at a one-year
follow-up (Carlson et al., 2007). Pace et al. (2009) and Tang et al. (2007) demonstrated
that short-term meditation interventions were related to changes in immune and
neuroendocrine functioning in healthy student samples following an experimental
stressor. Specifically, participants who received mindfulness training showed reductions
in IL-6 (Pace et al., 2009) and cortisol (Tang et al., 2007), and increases in salivary IgA
(Tang et al., 2007). Short-term interventions consisted of two 50-minute sessions per
week over the course of 6-weeks (Pace et al., 2009), and one 20-minute session for five
consecutive days (Tang et al., 2007). Lastly, some studies report that treatment
adherence or home practice is positively associated with immune outcomes (Creswell et
al., 2009; Pace et al., 2009), while others have not observed this effect (Carlson et al.,
2007).
Although results are encouraging, these investigations are not without
methodological limitations. Some studies have failed to include control conditions
(Carlson et al., 2003; 2007), which significantly limits conclusions regarding the effects
of MBSR on immunity. Many studies have neglected to assess participants
longitudinally (Davidson et al., 2003; Tang et al., 2007, Witek-Janusek et al., 2008,
Creswell et al., 2009, Pace et al., 2009), making it difficult to evaluate if MBSR training
has an enduring impact on immune processes. Pertinent to the current study, Pace et al.
(2009) reported significantly reduced levels of IL-6 in participants in a short-term
mindfulness intervention following an experimental stressor. However, this effect was
only seen in participants who reported high levels of meditation practice outside of
sessions. Furthermore, although this group showed a significant change from pretreatment, no significant difference in level of IL-6 was observed between the meditation
group and an attention-control group following treatment. The lack of between-group
effect may have been the result of using a non-psychologically vulnerable population or
teaching a meditation practice not common to MBSR structure (i.e., compassion
meditation). Finally, while investigations examining the effects of mindfulness training
on immunocompromised populations (e.g. HIV, cancer) are necessary and informative,
they shed little light on the effects of mindfulness on immunity in otherwise healthy
people with depression. Although diseases such as cancer share similarities with
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depression, in that both conditions elevate circulating pro-inflammatory cytokines, it is
difficult to interpret immunological findings from these populations. That is, reductions
in cytokines may be attributed to cancer recovery, reductions in depression, or both. For
this reason, it is necessary to investigate immunological changes following mindfulness
training in a depressed but immunocompetent (or otherwise healthy) sample.
Summary and Significance
Investigations examining the effects of mindfulness practice on previously and
acutely depressed individuals show clinically significant improvements in functioning
across a number of domains. In addition, mindfulness practice appears to contribute to
optimal immune functioning in both normal and clinical populations. However, it
remains unknown how mindfulness practice relates to immune changes in an
immuncompetent depressed population. There is also limited research on the long-term
benefits participants receive following mindfulness-based interventions.
The current study investigated the effects of a short-term mindfulness intervention
on psychological and immune functioning in a sample with moderate depressive
symptoms. This study assessed all participants from baseline to post-treatment.
Participants in the mindfulness intervention were further evaluated at a 3-month followup point to assess maintenance of treatment gains. Recent evidence (Tang et al., 2007;
Pace et al. 2009) has demonstrated the potential benefits of short-term meditation practice
on attention, emotion, and immunity, and showed that number of in-class hours is not
strongly related to psychological outcomes in clinical and non-clinical samples (Carmody
& Baer, 2009). These findings suggest that short-term mindfulness interventions may
provide benefits equivalent to those received in standard 8-week courses.
This study was designed to improve upon previous investigations of immune
function and mindfulness training by: 1) monitoring an immune variable relevant to
depressive symptoms, 2) longitudinally assessing immune and psychological outcomes,
3) recruiting a psychologically vulnerable yet immunocompetent population, and 4)
evaluating a mechanism of action responsible for reducing levels of pro-inflammatory
immune correlates of depression.
Study Aims and Hypotheses
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Aim 1. To assess the longitudinal effects of a short-term mindfulness
intervention on immunity and psychological health in a sample with moderate depressive
symptoms.
Hypothesis 1: Compared to a contact-control group, individuals participating in
the mindfulness intervention will show reductions in two pro-inflammatory immune
correlates of depression: interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), at
immediate post-intervention assessment.
Hypothesis 2: Compared to a contact-control group, individuals participating in
the mindfulness intervention will experience reductions in self-reported depression,
psychological and physical symptoms, and emotional dysregulation, and report
improvements in psychological well-being and the tendency to be mindful in daily life at
immediate post-intervention assessment.
Hypothesis 3: For participants in the mindfulness intervention, improvements in
immunity and psychological health are expected to remain relatively stable at a 3-month
follow-up assessment.
Aim 2. To examine a possible mechanism of action responsible for reduction in
pro-inflammatory immune correlates of depression.
Hypothesis 4: At immediate post-intervention assessment, self-reported
depression is expected to mediate the relation between treatment condition (mindfulness
training vs. contact-control) and pro-inflammatory immune correlates of depression (IL-6
and TNF-α).
Although recent commentary (Howren et al., 2009) suggests that the association
between depression and pro-inflammatory cytokines is likely the result of a bidirectional
process, this study proposes that reductions in self-reported depression will lead to
reductions in IL-6 and TNF-α. Because mindfulness training targets disruptive cognitive
and affective states through exercises emphasizing non-judgmental observation and
acceptance, it seems reasonable to conclude that depressive symptoms will initially
decrease, thereby diminishing potential mediators of pro-inflammatory immune
activation (e.g., stress hormones).

Copyright © Erin Celine Walsh, 2011
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Section Two: Method
Overview of Study Design
This was a longitudinal intervention study of young women with moderate
depressive symptoms. Participants were assigned to either a mindfulness training or a
contact-control condition. Over the course of the investigation, participants completed
three separate assessments: (a) before treatment initiation (baseline), (b) following
treatment completion (6-week post-treatment assessment), and (c) 3-months after
treatment completion (3-month follow-up; mindfulness training only). At each time
point, self-report data and salivary cytokines (IL-6, TNF-α) were assessed. Data were
collected between September 2010 and June 2011. Complete information on participant
flow is presented in the Results section (based on the consolidated standards of reporting
trials [CONSORT] recommendations) and can be viewed in Figure 2.1.
Participant Recruitment and Allocation
Initial Screening. At the beginning of the Fall 2010 and Spring 2011 semesters,
all students in introductory psychology at the University of Kentucky were offered the
opportunity to participate in an in-class screening session for course credit. During this
session students filled out an approved screening questionnaire, the Center for
Epidemiological Depression Scale (CES-D; Radloff, 1977), assessing their current level
of depression. Students who endorsed moderate symptoms of depression (scores ranging
from 16-24) were contacted about their interest in participating in the current study and
invited to complete a phone screening with the PI.
Phone Screening. During the phone screening, potential participants were
informed that the purpose of the study was to examine the effects of mindfulness
meditation and yoga on health and well-being. Potential participants were told that they
would have to complete the phone screening to determine if they met eligibility criteria
for the study. Eligibility criteria included: (a) endorsement of moderate depressive
symptoms based upon self-report screening measure, (b) ages 18-25 years old, (c) female,
(d) absence of suicidal ideation and suicide intent/plan, (d) absence of specific psychiatric
disturbance (i.e., psychosis, bipolar disorder, PTSD), (e) absence of alcohol/drug
dependence, (f) absence of immune disease or disorder (e.g., lupus, HIV), (g) absence of
pregnancy, (h) not currently taking psychotropic agents (i.e., anti-depressants,
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anxiolytics, anti-psychotics), statins, beta-blockers, anti-hypertensives, and nonsteroidal
anti-inflammatory drugs, (i) willingness to be randomly assigned to the mindfulness or
contact-control condition, and (j) ability to read, write and understand English.
Group Assignment. Students who met criteria for the study following the phone
screening were assigned to a group. Four groups were run each semester (Fall 2010,
Spring 2011) to maximize the number of students who could be included in the study.
Groups typically took place in the early mornings (i.e., 8am or 9am) to increase the
likelihood that participants would adhere to study procedures on assessment days (see
below for more detail). Due to students’ schedule constraints, unrestricted randomization
was not possible. Therefore, group allocation procedures were as follows: a) If a student
could participate in any of the available group times, she was randomized to a group; b)
If a student could only participate in a restricted number of groups, she was randomized
to a group that fit within her schedule; and c) If a student could only participate in one
group due to schedule constraints, she was assigned to that particular group. The PI and
students were blind to condition until all eligible participants were enrolled each
semester. Once study enrollment was complete, the PI randomized condition for each
group (i.e., mindfulness training or contact-control) such that there were two mindfulness
training and two contact-control groups offered each semester. Participants learned of
their condition status at the baseline assessment. All randomization procedures were
completed with the assistance of an online random number generator (www.random.org).
Study Procedures
Baseline Assessment (Session 1). At the agreed upon day and time, the PI met
with each group, consisting of no more than 20 members each. After completion of
informed consent procedures, participants were asked to complete a packet of self-report
measures assessing psychological and physical health status. Additionally, participants
were asked to provide a saliva sample for assessment of immune function. Following
collection of these measures, the PI provided participants with a brief overview of the
study, including information on what they would be asked to do each week. Contactcontrol participants were informed that they could participate in a short-term mindfulness
course the following semester, if interested. Completion of the baseline assessment took
50 minutes.
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Mindfulness Training Sessions. All mindfulness training sessions were
completed in weeks 2-5 following baseline assessment. Participants met in groups with
the PI once per week to practice a specific mindfulness exercise. Each session included
35 minutes of mindfulness practice and 15 minutes of discussion (e.g., discussion of
weekly experience, applicability of practice to daily life). At the end of each session,
participants were given a take-home CD of the mindfulness practice reviewed that week.
Although it was optional, participants were encouraged to practice the mindfulness
exercise while at home. They were provided with daily tracking logs to record the
number of minutes they attempted any formal meditation practice. Only two participants
attempted at-home practice over the course of the study. Due to insufficient
participation, this variable was not included in any final analyses.
•

Body Scan (Session 2): The PI led participants through an exercise asking them to
non-judgmentally observe sections of their body (e.g., toes, thighs, back, neck).
Emphasis was placed on examining the sensations present in each location. Practice
began and ended with attention to the breath, and is described in Segal et al. (2002).

•

Sitting Meditation (Sessions 3 & 5): The PI led participants through an exercise
asking them to non-judgmentally observe: 1) the sensations of breathing, 2) the
sensations present in the body, 3) the content of thoughts, 4) the presence of
emotions, and 5) the sounds in the environment. Practice began and ended with
attention to the breath, and is described in Segal et al. (2002). As sitting meditation
receives considerable attention in mindfulness-based interventions, two sessions were
devoted to this exercise.

•

Yoga (Session 4): The PI led participants through light stretching exercises
described in Kabat-Zinn (1990). Participants were asked to focus nonjudgmentally
on the particular sensations associated with bodily movement. Modified poses were
provided to participants who were unable to perform the full range of movement for a
specific yoga pose. Practice began and ended with focus on the breath.
Contact-control Sessions. Participants in the contact-control groups were asked

to fill out questionnaires unrelated to the proposed study, in weeks 2-5, following
baseline assessment. Participants met in groups once per week, and each session lasted
50 minutes.
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Post-treatment Assessment. During week 5, participants were reminded of the
upcoming post-treatment assessment. Participants were asked to return the following
week at the agreed upon date, time, and location to complete assessment measures
equivalent to those collected during the baseline session. At this assessment, participants
in the contact-control groups were invited to take part in a short-term mindfulness course
the following semester. Interested students were told to contact the PI if they wished to
participate. No contact-control participants opted to receive mindfulness training once
the study was complete. Completion of the post-treatment assessment session took 50
minutes.
3-month Follow-up Assessment (mindfulness training ONLY). One month prior
to the 3-month follow-up, the PI sent an email to mindfulness training participants
reminding them of the final follow-up assessment. Participants met with the PI in small
groups or individually to complete self-report and salivary assessment measures. These
sessions were held approximately three months following completion of the 6-week
follow-up and lasted 40-50 minutes. A total of 21 participants attended this session and
provided complete follow-up data. An additional three participants who were willing to
complete the 3-month assessment yet could not attend due to being out of state were
mailed a packet of self-report questionnaires but did not complete the salivary
assessment. These participants filled out and returned the packets within 2 weeks.
Individuals in the contact-control group were not evaluated at the 3-month followup. Based upon the University of Kentucky IRB requirements, participants in the contactcontrol group were offered the described mindfulness intervention immediately following
the 6-week post-treatment assessment. Because we could not predict whether participants
would engage in the treatment at the start of the following semester, and thereby
confound potential results, we chose not to assess them at this time point.
Procedures for Enhancing Recruitment and Retention. To increase recruitment
and retention, participants received course credit for the baseline assessment and each
intervention session attended, and $20 was awarded to participants who attended all of
these sessions. In addition, $20 was offered for completion of the post-treatment and 3month follow-up sessions.
Psychological Measures
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Depressive Symptoms. The Center for Epidemiologic Depression Scale (CES-D)
is a 20-item inventory of depressive symptoms (Radloff, 1977). The CES-D asks
participants to rate their mood, thoughts, and behavior during the previous week on a 4point Likert scale. CES-D items were scored such that higher total scores were indicative
of greater depressive symptoms. For the current study, scores ranging from 16-24 were
used to screen for moderate symptoms of depression (Greden & Schwenk, 1997). The
CES-D was also administered at all study time points to monitor changes in depression
severity. For the present sample, internal consistencies were as follows: Baseline
assessment (α = .80), post-treatment assessment (α = .79), 3-month follow-up (α = .65).
Structured Clinical Interview for DSM-IV-TR Axis-I Disorders (SCID-I). The
SCID-I is a semi-structured interview used to diagnose the major Axis I DSM-IV-TR
disorders (First et al., 1994). The SCID-I can be administered in full (i.e. all modules) or
adapted to assess particular diagnostic classes of interest. For the current study, the
following modules were used during the phone screening to identify students who were
ineligible due to the presence of particular disorders: Major Depressive Disorder (for
severe symptom severity and suicidality), Substance Use Disorders (for alcohol/drug
dependence), Bipolar I/II Disorder (for symptoms of severe depression or mania), and
PTSD (for symptoms of severe anxiety and post-traumatic stress). Additionally, items
measuring extreme psychotic symptoms were used to screen out participants with
psychosis.
Psychological Symptoms. The Brief Symptom Inventory (BSI) is a 53-item selfreport instrument that assesses current psychopathology. It contains nine symptom
dimensions (Somatization, Obsessive-Compulsiveness, Interpersonal Sensitivity,
Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism)
and a Global Severity Index (GSI) that represents overall psychological distress. Only
the GSI was used in the present study. The BSI has demonstrated high internal
consistency and significant associations with measures of similar constructs. Participants
completed the BSI at all three assessments. Internal consistencies for GSI were as
follows: Baseline assessment (α = .91), Post-treatment assessment (α = .89), 3-month
follow-up (α = .91).
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Emotion Regulation. The Difficulties in Emotion Regulation Scale (DERS) is a
36-item measure designed to assess deficits in emotion regulation (Gratz & Roemer,
2004). It includes six subscales: Lack of Acceptance of Emotional Responses, Lack of
Emotional Awareness, Lack of Emotional Clarity, Limited Access to Effective Emotion
Regulation Strategies, Lack of Impulse Control, and Difficulties Engaging in GoalDirected Behavior when experiencing distress. Higher scores indicate greater emotion
dysregulation. In the development sample, the DERS demonstrated good test-retest
reliability and significant associations with measures of similar constructs. Participants
completed the DERS at all three assessments. Internal consistencies for subscales were as
follows: Baseline assessment (α ranging from .55-.88), Post-treatment assessment (α
ranging from .74-.90), 3-month follow-up (α ranging from .79-.90).
Physical symptoms. Self-perceived health was assessed with the Pennebaker
Inventory of Limbic Languidness (PILL; Pennebaker, 1982). The PILL is a 54-item scale
that measures the frequency of experiencing common physical symptoms and sensations
(e.g., indigestion, headaches, nausea). The PILL demonstrates high internal consistency
and has been shown to correlate moderately with similar symptom scales (Pennebaker,
1982). For the present study, the PILL was completed at all three assessments and
internal consistencies were as follows: Baseline assessment (α= .91), Post-treatment
assessment (α= .92), 3-month follow-up (α= .96).
Mindfulness. The Five Facet Mindfulness Questionnaire (FFMQ) is a 39-item
self-report questionnaire designed to measure five facets of mindfulness: Observing,
Describing, Acting With Awareness, Nonjudging of experience, and Nonreactivity to
inner experience (Baer et al., 2006). The FFMQ has shown good internal consistency for
the five facets, and has demonstrated convergent and discriminant validity with several
measures of related constructs. Furthermore, all facets appear to be distinct from one
another, exhibiting only moderate inter-correlations. The FFMQ was completed at all
three assessments and internal consistencies for subscales were as follows: Baseline
assessment (α ranging from .81-.86), Post-treatment assessment (α ranging from .65-.91),
3-month follow-up (α ranging from .74-.88).
Well-being. The Scales of Psychological of Well-Being (PWB) assess six
subscales: Self-Acceptance, Environmental Mastery, Positive Relations with Others,
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Personal Growth, Purpose in Life, and Autonomy (Ryff, 1989). Higher scores reflect
greater well-being. Validity of the PWB scores is evidenced by significant positive
correlations with measures of positive functioning (i.e. life satisfaction, self-esteem) and
negative correlations with measures of negative functioning (i.e. depression) (Ryff,
1989). Participants completed the PWB at all three assessments. Internal consistencies
for subscales were as follows: Baseline assessment (α ranging from .64-.81), Posttreatment assessment (α ranging from .73-.84), 3-month follow-up (α ranging from .72.86).
Biological Measures
Salivary cytokine samples. Although typically assessed in serum levels, studies
show that IL-6 and TNF-α can be detected in whole unstimulated saliva (Sjogren et al.,
2006; Tishler et al., 1999; Pezelj-Ribaric et al., 2004), which is less invasive to collect
than serum. For the current study, the “passive drool” method was used to collect saliva
samples. Twenty-four hours prior to each saliva sample collection, participants were
asked to abstain from caffeine, tobacco, and alcohol products, illicit drugs, and exercise,
until the assessment was complete (e.g., caffeine has immunosuppressive effects on proinflammatory cytokines, see Horrigan et al., 2006). To collect whole, unstimulated
saliva, participants were asked to rinse their mouths with bottled water for 30 seconds
and immediately dispose of the water into a paper cup, which was subsequently thrown
away. They were then instructed to wait 10 minutes before filling a small tube with 25ml of their saliva (Sarstedt AG & CO). Saliva was initially stored for 1-4 weeks ay 25˚C before being transferred to -80˚C before assay. Immunoassays were performed at
the Clinical Research Development and Operations Center (CR-DOC) at the University
of Kentucky in Lexington, KY.
Potential Covariates
General health questionnaire. Demographic information (age, race/ethnicity,
marital status, current grade, religious affiliation), history of psychotherapy, and history
of mindfulness practice were collected at baseline assessment. At all assessment points,
participants reported on health-related information, including: height and weight (to
calculate BMI); history of health problems (e.g., allergies, cardiac illness, cancer, sleep
disturbance); medications; illness (e.g., flu, cold); injury; vaccination status;
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hospitalizations or surgeries; oral contraception use; menstrual cycle day/phase; oral
health; caffeine, alcohol, and drug use; and amount of physical activity.
The purpose of assessing this information was to control for potential variables
that might affect levels of circulating pro-inflammatory cytokines. Recent commentary
(Segerstrom, 2009; O’Connor et al., 2009) recommends not controlling for variables
unless there is a strong theoretical reason to do so. Segerstrom (2009) argues that
overfitting a model will have adverse effects on statistical power, results, and
replicability. Therefore, the only a priori variable that was entered as a covariate was oral
contraception use. For the remaining variables, correlations with IL-6 and TNF-α were
computed. Only variables that were significantly correlated with salivary cytokines were
included as covariates in subsequent analyses.
Data Screening
Several dependent variables did not meet the regression assumption of normality
(i.e., the skewness for a given dependent variable was more than three times the standard
error of its skewness). In each such case, an attempt was made to achieve normality
using nonlinear transformations (i.e., square root, log 10). For the following variables,
square root transformations were adequate for achieving normality: CES-D and Lack of
Emotional Clarity (DERS). For Lack of Impulse Control (DERS) and Lack of
Acceptance of Emotional Responses (DERS), log 10 transformations were required to
achieve normality. The following variables followed a poisson distribution and could not
be transformed to normality using a nonlinear transformation: IL-6 and TNF-α. The
remaining outcome variables were normally distributed. Between-person covariates (e.g.,
BMI) were always grand-mean centered for use as predictors.
Statistical Analyses
Because some outcome data were missing at random, missing values were
imputed using multiple random imputation in SAS PROC MI. To test the prediction that
mindfulness training would be associated with lower levels of symptoms at posttreatment assessment controlling for baseline levels, regression models were fit in SAS
PROC REG with baseline levels of the relevant outcome measure in step 1, and condition
(with mindfulness condition coded as 1, and contact-control condition coded as 0) in step
2. For outcome variables that appeared to follow a poisson distribution and could not be
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transformed to normality using a nonlinear transformation, similar regression models
were fit in SAS PROC GENMOD specificying a poisson distribution for the dependent
variable. Where significant effects of condition were not found, paired sample t-tests
were also carried out to determine whether the outcome variable changed pre-post
intervention in the whole sample, regardless of condition. Analyses were carried out on
each of 20 data sets, imputed using SAS PROC MI, and results were combined using
SAS PROC MIANALYZE, which provides 95% confidence intervals for model
estimates.
To test the prediction that improvements in pro-inflammatory cytokine levels and
psychological health would remain significant at the 3-month follow-up for those in the
mindfulness intervention, two paired sample t-tests were carried out for each outcome
that showed 1) significant changes from baseline to post-intervention in the full sample,
or 2) a significant effect of the mindfulness condition on changes from baseline to postintervention. The first paired sample t-test addressed whether the difference between
baseline and post-intervention assessments was significant within the mindfulness
condition, and the second addressed whether the difference between baseline and 3month follow-up assessments was significant in the mindfulness condition.

Copyright © Erin Celine Walsh, 2011
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Figure 2.1
Flowchart for participant progress (based on the consolidated standards of reporting trials [CONSORT] recommendations)
Enrollment

Excluded (n=15)
♦ Not meeting inclusion criteria (n=13)
• Psychotropic medication (n=6)
• Immune disorder (n=4)
• Age (n=2)
• Psychiatric diagnoses (n=1)

Assessed for eligibility
(n=79)

Group Assignment (n=64)
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Allocation
Allocated to Mindfulness intervention (n=31)
♦ Received allocated intervention (n=31)

Allocated to Contact-control condition (n=33)
♦ Received allocated intervention (n=33)
Follow-Up

Lost to follow-up at post-treatment (n=1)
♦ No contact/Unknown reason

Lost to follow-up at post-treatment (n=1)
♦ Oversleeping

Lost to follow-up at 3-month assessment (n=7)
♦ No contact/Unknown reason (n=6)
♦ Moved out of state (n=1)
Analysis
Analyzed (n=30)
♦ Excluded from analysis for cold/virus (n=1)

Analyzed (n=31)
♦ Excluded from analysis for cold/virus (n=2)

Section Three: Results
Participant Flow
Over the course of the study, 79 female students were assessed for study
eligibility. Figure 2.1 provides information on accrual and retention of study participants
(based on the consolidated standards of reporting trials [CONSORT] recommendations).
Fifteen students from the initial pool of 79 were excluded for not meeting inclusion
criteria (n=13) or were not interested in participating in the study once contacted (n=2).
Sixty-four students met eligibility criteria and were assigned to either a mindfulness
training group (n=31) or a contact-control group (n=33). At the post-treatment
assessment, 62 participants had completed the study (mindfulness training=30; contactcontrol=32). One participant dropped out for unknown reasons while the other missed
the assessment due to oversleeping. Twenty-four participants in the mindfulness group
completed the 3-month follow-up assessment (retention=77%). Out of the seven
participants who withdrew from the study, six did not respond to the PI’s queries to
return for the final follow-up session, and one reported she was not able to participate due
to moving out-of-state. Participants who completed the 3-month follow-up were similar
to those who did not complete the 3-month follow-up with respect to age, race/ethnicity,
current grade, marital status, and religious affiliation (all p’s > .10).
Baseline Data
Descriptive statistics for the sample by condition can be found in Table 3.1. There
were no significant differences in age, race/ethnicity, current grade, or religious
affiliation between the two conditions (age: t(62) = -.18, p = .86; race: X2(2) = 2.19, p =
.33, current grade: X2(2) = 1.44, p = .49, religious affiliation: X2(2) = 1.24, p = .74). No
significant correlations were found between these demographic variables and baseline
levels of IL-6 or TNF-α. Descriptives for outcome variables at baseline and posttreatment for the full sample and within each condition can be found in Table 3.2.
Aim 1: Treatment Effects
Condition Effects on Salivary Cytokines
Estimates and 95% confidence intervals for poisson regression models predicting
the effect of condition on cytokine levels at post-treatment controlling for cytokine levels
at baseline are presented in Table 3.3. As noted earlier, oral contraceptive use was
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controlled for a priori. Upon inspection of correlations between levels of IL-6, TNF-α,
and variables measured in the general health questionnaire, only one significant
correlation emerged: TNF-α and BMI were positively correlated. Therefore, oral
contraceptive use was controlled for in the model predicting IL-6, and both oral
contraceptive use and BMI (standardized) were controlled for in the model predicting
TNF-α. Results indicated that, controlling for baseline levels of IL-6, participation in
mindfulness training predicted lower IL-6 at the post-treatment assessment (BCONDITION= .61, SE = .17, 95% CI: -.95 to -.26, p = .0006). See Figure 3.1 for a graph of condition
effects on IL-6 from baseline to post-treatment. Likewise, controlling for baseline levels
of TNF-α, participation in mindfulness training was associated with lower levels of TNFα at post-treatment (BCONDITION = -.37, SE = .23, 95% CI: -.86 to -.12, p = .04). See
Figure 3.2 for a graph of condition effects on TNF-α from baseline to post-treatment.
Condition Effects on Self-Report Outcomes
Estimates and 95% CIs for regression models predicting post-treatment
depression scores indicated that change in depression was not significantly associated
with condition (CES-D: BCONDITION = 1.06, SE = 1.22, 95% CI: .67 to 1.56, p = .39).
However, depression decreased from baseline to post-treatment regardless of condition
(CES-D: Mean Difference: -3.10, 95% CI = -4.59 to -1.61, t = -4.08, p < .0001). Results
of regression estimates predicting psychological symptoms as measured by the GSI
(BSI), Deficits in Emotion Regulation as measured by the DERS, and Physical
Symptoms as measured by the PILL also indicated that change in these measures was not
significantly associated with condition. However, general psychological symptoms
decreased from baseline to post-treatment regardless of condition (Global Severity Index,
GSI, Mean Difference = -.13, 95% CI = -.053 to -.20, t = 2.45, p = .02).
With regard to mindfulness facets, those in the mindfulness condition had higher
levels of Observe at post-treatment than those in the contact-control condition controlling
for baseline levels (BCONDITION = .34, SE = .18, 95% CI: .0079 to .69, p = .05), and those
in the contact-control condition had higher levels of Nonjudging at post-treatment than
those in the mindfulness condition controlling for baseline levels (BCONDITION = -.35, SE =
.11, 95% CI: -.57 to -.12, p = .0025). See Figures 3.3 and 3.4 for graphs of respective
results. Levels of other facets of mindfulness at post-treatment were not significantly
18

associated with condition when controlling for baseline levels. With regard to
psychological well-being, condition was not significantly associated with levels of
psychological well-being at post-treatment controlling for baseline levels. However,
levels of Personal Growth increased from baseline to post-treatment regardless of
condition (Mean Difference = .11, 95% CI = .0021 to .21, t = 2.00, p = .045).
Longitudinal Outcomes within the Mindfulness Training Condition
Additional within-group analyses were conducted within the mindfulness
condition to investigate 1) the significance of within-condition effects of time at posttreatment, and 2) whether significant changes within the mindfulness condition at posttreatment were maintained at 3-month follow-up (i.e., whether the difference between
baseline and 3-month measures were also significant in expected directions). Results
indicate that, within the mindfulness condition, IL-6 decreased significantly from
baseline at both post-treatment and 3-month follow-up assessments (Mean Difference
from baseline to post-treatment = -.58, 95% CI = -.27 to -.98, t = -2.38, p = .019; Mean
Difference from baseline to 3-month follow-up = -.75, 95% CI = -.45 to -1.87, t = -1.98,
p = .054). Identical analyses carried out for TNF-α suggested that, although TNF-α
decreased significantly from baseline to post-treatment, the decrease from baseline to the
3-month follow-up assessment was only marginally significant, suggesting that changes
in TNF-α may have been less robust (Mean Difference from baseline to post-treatment =
-.53, 95% CI = -1.05 to -.41, t = -2.38, p = .008; Mean Difference from baseline to 3month follow-up = -.45, 95% CI = -1.48 to .72, t = -1.21, p = .11). Results for depression
scores indicated that the CES-D decreased significantly from baseline to post-treatment
(Mean Difference from baseline to post-treatment = -2.71, 95% CI = -3.46 to -1.83, t = 2.35, p = .018) and from baseline to the 3-month follow-up (Mean Difference from
baseline to 3-month follow-up = -2.76, 95% CI = -5.19 to -.32, t = -2.25, p = .026).
Additionally, decreases in GSI, though only marginally significant at post-treatment,
were statistically significant at the 3-month follow-up (Mean Difference from baseline to
post-treatment = -.10, 95% CI = -.22 to .04, t = -1.53, p = .13; Mean Difference from
baseline to 3-month follow-up = -.25, 95% CI = -.38 to -.13, t = -2.51, p = .0075). With
regard to the Observe facet of the FFMQ, increases were significant at post-treatment
(Mean Difference from baseline to post-treatment = .29, 95% CI = .14 to .58, t = 2.01, p
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= .044) but not at 3-month follow-up (Mean Difference from baseline to 3-month followup = .31, 95% CI = -.35 to .98, t = .94, p = .35). Finally, results indicate that changes in
Personal Growth were not significant at either from baseline to post-treatment or from
baseline to the 3-month follow-up (Mean Difference from baseline to post-treatment =
.13, 95% CI = -.08 to .35, t = 1.22, p = .22; Mean Difference from baseline to 3-month
follow-up = .11, 95% CI = -.25 to .48, t = .63, p = .53).
Aim 2: Potential Mediators of Cytokine Outcomes
Because there were no effects of mindfulness training on depression,
hypothesized meditational models were not considered. However, several post-hoc
regression models were fit and combined using PROC MIANALYZE to explore other
potential mediators of the effects on salivary cytokines. First, because there were
condition effects on changes in the Observe subscale of the FFMQ, this scale was
examined as a potential mediator. However, changes in the Observe subscale were not
significantly related to cytokines at time 2 controlling for cytokines at time 1 (IL-6:
BOBSERVECHANGE = -.049, SE = .16, 95% CI: -.28 to .17, p = .76; TNF-α: BOBSERVECHANGE
= -.074, SE = .15, 95% CI: -.12 to .20, p = .62). Next, we explored condition effects on
changes in several health behaviors, including physical activity, caffeine and alcohol
consumption. Results indicated that condition was not associated with health behaviors
at time 2 controlling for the relevant health behaviors at time 1 (Minutes of Physical
Activity per Week: BCONDITION = 7.03, SE = 3.75, 95% CI: -1.59 to 1.12, p = .85; Units of
Caffeine per Day: BCONDITION = -2.09, SE = 2.30, 95% CI: -5.91 to 1.73, p = .93; Units of
Alcohol per Week: BCONDITION = 2.48, SE = 4.16, 95% CI: -6.08 to 1.10, p = .95).
Therefore, condition effects on health behaviors do not appear to be responsible for
condition effects on changes in salivary cytokines.

Copyright © Erin Celine Walsh, 2011
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Table 3.1
Descriptives by Sample
Variable

Mindfulness
Condition

ContactControl
Condition

Age: M (SD)
19.15 (.17)
19.11 (.16)
Grade Level: N (%)
Freshman
22 (70%)
27 (82%)
Sophomore
6 (20%)
3 (9%)
Junior
3 (10%)
3 (9%)
Race: N (%)
Caucasian
25 (81%)
30 (91%)
African-American
4 (13%)
1 (3%)
Asian
2 (6%)
2 (6%
Religious Affiliation: N (%)
Christian
26 (84%)
25 (76%)
Hindu
1 (4%)
1(3%)
No Religious Affiliation
2 (6%)
5 (15%)
No Answer
2 (6%)
2 (6%)
Note. Standard Deviations and Within-group Percentages in Parentheses
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Table 3.2
Means and Standard Deviations for Outcome Variables at Baseline and Post-treatment by Condition
Variable

IL-6

Full Sample
PRE
POST
M (SD)
M (SD)
3.58 (4.55)
3.14 (5.36)

Mindfulness Condition
PRE
POST
M (SD)
M (SD)
3.50 (5.14)
2.20 (2.24)

Contact-Control Condition
PRE
POST
M (SD)
M (SD)
3.66 (4.01)
4.04 (7.14)

TNF-α

2.21 (2.95)

1.64 (1.68)

2.13 (3.76)

1.33 (1.42)

2.29 (1.93)

1.94 (1.87)

12.53a (6.25)

9.44b (5.64)

13.26a (5.67)

10.30b (5.89)

11.85a (6.76)

8.63b (5.36)

GSI (BSI)

.51a (.30)

.40b (.25)

.53 (.31)

.43 (.24)

.48a (.30)

.37b (.26)

PILL total

1.81 (.36)

1.75 (.39)

1.78 (.33)

1.73 (.34)

1.84 (.38)

1.77 (.43)

Lack of Emotional
Awareness (DERS)

2.58 (.72)

2.47 (.70)

2.56 (.82)

2.44 (.71)

2.60 (.64)

2.50 (.71)

Lack of Emotional Clarity
(DERS)

2.14 (.63)

2.20 (.60)

2.26 (.76)

2.27 (.64)

2.02 (.45)

2.12 (.55)

Lack of Acceptance of
Emotional Responses
(DERS)

1.90 (.70)

1.94 (.80)

1.84 (.58)

2.00 (.86)

1.95 (.80)

1.88 (.74)

Limited Access to
Strategies (DERS)

1.73 (.47)

1.71 (.53)

1.77 (.45)

1.68 (.48)

1.68 (.50)

1.75 (.58)

CES-D total
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Table 3.2 (Continued)
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Lack of Impulse Control
(DERS)

1.57 (.38)

1.53 (.45)

1.54 (.37)

1.45 (.41)

1.59 (.39)

1.60 (.48)

Difficulties with Goal-Directed
Behavior (DERS)

2.87 (.77)

2.81 (.83)

2.91 (.86)

2.90 (.84)

2.82 (.70)

2.73 (.82)

Observe (FFMQ)

3.44 (.83)

3.49 (.82)

3.32a (.83)

3.57b (.75)

3.54 (.82)

3.41 (.89)

Describe (FFMQ)

3.40 (.67)

3.39 (.78)

3.29 (.80)

3.35 (.83)

3.46 (.53)

3.43 (.75)

Nonjudging (FFMQ)

3.81 (.68)

3.88 (.64)

3.80 (.69)

3.70 (.65)

3.81a (.67)

4.04b (.60)

Nonreactivity (FFMQ)

2.88 (.60)

2.89 (.50)

2.86 (.67)

2.90 (.48)

2.89 (.53)

2.88 (.52)

Acting with Awareness
(FFMQ)

3.58 (.65)

3.47 (.69)

3.50 (.66)

3.38 (.74)

3.66 (.64)

3.55 (.63)

Autonomy (PWB)

4.18 (.72)

4.16 (.73)

4.17 (.74)

4.18 (.78)

4.20 (.72)

4.14 (.69)

Environmental Mastery (PWB)

4.27 (.69)

4.40 (.61)

4.21 (.73)

4.40 (.57)

4.33 (.67)

4.39 (.66)

Self-Acceptance (PWB)

4.71 (.66)

4.72 (.68)

4.79 (.64)

4.90 (.57)

4.64 (.68)

4.55 (.75)

Positive Relations (PWB)

4.67 (.79)

4.75 (.78)

4.56 (.82)

4.64 (.80)

4.78 (.76)

4.85 (.77)

Purpose in Life (PWB)

4.70 (.55)

4.69 (.60)

4.75 (.58)

4.76 (.65)

4.66 (.52)

4.63 (.56)

Personal Growth (PWB)
4.91a (.59)
5.02b (.67)
5.01 (.62)
5.04 (.68)
4.81a (.56)
Note: Differing superscripts indicate significant differences between baseline and post-treatment values (p<.05).

5.00b (.67)

Table 3.3
Estimates for Poisson Regression Models Predicting IL-6 and TNF-α Using PROC
MIAnalyze
Variable

Estimate

95% CI for Estimate

Oral Contraceptive Use

-.70*

-1.06 to -.34

Time 1 IL-6

.30*

.18 to .41

MBSR Condition

-.60*

-.95 to -.26

Oral Contraceptive Use

-.66*

-1.14 to -.17

Body Mass Index

.12

-.10 to .35

Time 1 TNF-α

.30*

.15 to .44

MBSR Condition

-.37*

-.86 to -.12

Interleukin-6

Tumor Necrosis Factor-α

Note: *p < .01
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Figure 3.1
Effect of Condition on Change in IL-6 Pre-to-Post-Treatment
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Figure 3.2
Effect of Condition on Change in TNF-α Pre-to-Post-Treatment
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Figure 3.3
Effect of Condition on Change in Observe Pre-to-Post-Treatment
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Figure 3.4
Effect of Condition on Change in Nonjudging Pre-to-Post-Treatment
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Section Four: Discussion
The present study investigated whether a short-term mindfulness-based
intervention could reduce both immunological and psychological features of depression
in a sample of moderately depressed college women. The first hypothesis was that
participation in the mindfulness group would be associated with post-treatment
reductions in pro-inflammatory immune correlates of depression: IL-6 and TNF-α. This
hypothesis was supported. Compared to a contact-control group, participants in the
mindfulness intervention showed significant reductions in these two immune variables.
The second hypothesis was that participation in the mindfulness group also would be
associated with changes in several self-reported psychological variables, including
depression, general distress, well-being, emotion regulation, and mindfulness. This
hypothesis was not supported. Although improvements in several psychological
variables were observed, very few between-group differences emerged. The Observe
facet of the FFMQ was shown to significantly increase in the mindfulness group only,
while the Nonjudging facet increased only in the contact-control group. The third
hypothesis was that, for participants in the mindfulness intervention, improvements in
immune and psychological health variables would remain stable over the 3-month
follow-up period. This hypothesis was partially supported. Within the mindfulness group,
reductions in both pro-inflammatory cytokines were sustained at a 3-month follow-up
assessment. However, because minimal differences in self-reported psychological
variables emerged pre-post-treatment, there were very few treatment effects in this
domain to monitor at the 3-month follow-up. While increases in the Observe facet were
significant from baseline to post-treatment in the mindfulness condition, these changes
were not maintained; however, reductions in psychological distress as measured by the
Global Severity Index (GSI) were significant from baseline to post-treatment and
maintained at 3-month follow-up in the mindfulness condition. The fourth hypothesis was
that self-reported depression at post-treatment would mediate the relationship between
participation in mindfulness training and changes in IL-6 and TNF-α. This hypothesis
was not tested because, contrary to expectations, the relation between participation in
mindfulness training and change in depression was not significant.
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Results for IL-6 and TNF-α are consistent with other investigations examining the
effects of short-term (e.g., Tang et al., 2007) or full-length (e.g., Carlson et al., 2007)
mindfulness-based interventions on immunity. For example, significant reductions in proinflammatory cytokines have been observed in cancer patients enrolled in 8-week
mindfulness courses (Carlson et al. 2003; Witek-Janusek et al., 2008) and these results
were sustained at a one-year follow-up (Carlson et al., 2007). Similar to these findings,
we observed significant reductions in cytokines pre-post treatment for the mindfulness
training group only and found that these improvements were maintained at 3-months
following treatment completion. However, this investigation is the first to demonstrate
such effects in a dysphoric yet immunocompetent sample and the first to include both a
control group and a post-treatment follow-up assessment. Furthermore, we provide
evidence that such reductions can occur with relatively brief training in mindfulness
practices. The current findings support the notion that mindfulness training may promote
immune responses that contribute to physical health (e.g., less inflammation). It
underscores the importance of examining such processes in future samples with
depressive disorders because doing so may illuminate the mechanisms by which
mindfulness contributes to improvements in psychological health.
The failure of the current study to find changes related to mindfulness training in
self-reported psychological variables is inconsistent with overwhelming evidence
suggesting that mindfulness training has direct benefits on many of the constructs
measured in this study (see Keng et al., 2011 for a review). Several factors may account
for these findings. One possibility is the low level of psychological distress in the sample.
Participants were recruited if they reported moderate levels of depressive symptoms
(scores of 16-24 on the CES-D) at the initial screening; however, mean levels of
depression had fallen to 12.53 (indicating minimal to mild symptoms) by the first session,
suggesting that the initial screening scores may have been temporary elevations related to
situational stress, rather than indicators of sustained depressive symptoms. As evidence
for this point, participants showed further decreases in depressive symptoms from pre- to
post-treatment. These changes are likely attributable to further regression to the mean as
the semester progressed. A second possibility is that the “dose” of mindfulness training in
the current study was not strong enough to effect changes in self-report measures that go
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beyond regression to the mean. Perhaps if participants had been provided with additional
training sessions (i.e., more than 4) or longer training sessions (i.e., more than 50
minutes), robust between-group differences in psychological variables may have
emerged. Several previous studies with comparable training lengths have reported
reductions in psychological symptoms or improvements in well-being in student samples
(Tang et al., 2007; Sauer et al., under review), while others have not (Pace et al., 2009).
Thus, this is an important area for further inquiry. A third potential factor is the nontreatment seeking status of the sample. Although they had reported moderate levels of
depression at the initial screening, they were not recruited from a help-seeking
population, but instead completed the study to meet a research participation requirement.
They engaged in very little home practice and may have had low levels of motivation to
learn mindfulness skills. Although a recent review (Carmody & Baer, 2009) found no
significant relationship between treatment duration and psychological symptom
reduction, suggesting that short treatment formats may be as effective as longer ones,
most of the reviewed studies used clinical populations or nonclinical samples seeking
help for stress reduction.
Despite its nonsignificant relationships with changes in self-reported
psychological functioning, the short-term mindfulness training provided in this study was
sufficient to lead to significant reductions in the two immune variables studied. It is
therefore important to consider how these immune changes occurred. It appears that they
are not accounted for by the self-report variables measured here. However, it is entirely
possible that we did not assess variables that could directly account for the significant
reductions in salivary cytokines. One particularly likely candidate is rumination.
Rumination is a transdiagnostic process, meaning that it is present in a multitude of
psychological disorders. Although definitions vary, it can be thought of as repetitively
focusing on one’s emotional experience, as well as the causes, consequences, and
implications of it (Aldao, Nolen-Hoeksema, & Schweizer, 2010). Individuals who
ruminate believe that it will help them solve problems or improve mood, however,
investigations show that rumination interferes with adaptive problem-solving (Aldao,
Nolen-Hoeksema, & Schweizer, 2010) and perpetuates negative mood (Thomsen,
Mehlsen, Christensen, & Zachariae, 2003). Mindfulness is thought to reduce rumination
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by teaching participants to defuse or decenter from thoughts via nonreactive observation
or to focus on other present-moment stimuli, such as the breath or bodily sensations
(Baer, 2007; Uebelacker et al., 2010). Investigations have shown that mindfulness
training is efficacious in reducing rumination in samples experiencing depressive or
general psychological symptoms (Kingston et al., 2007; Heeren & Philippot, 2011).
Additionally, Sauer, Walsh, Lykins and Eisenlohr-Moul (under review) showed that even
short-term, 3-session training in separate mindfulness practices led to significant
reductions in rumination. In fact, rumination was the only symptom that all mindfulness
practices significantly and robustly reduced. In regard to physiological correlates, there
is prospective evidence suggesting that rumination is associated with self-reported
somatic complaints (e.g., Thomsen et al., 2004a). Rumination is also linked to increases
in morning levels of cortisol (Schlotz et al., 2004), elevated leukocytes (Thomsen et al.,
2004b), and reductions in T-lymphocytes (Denson et al., 2010). These findings suggest
that rumination may have negative effects on one’s physical health. Because mindfulness
training is associated with reductions in ruminative tendencies, it is entirely plausible that
such changes may have mediated effects on cytokine levels in the present study.
Limitations
The present study has several limitations worth noting. First, as mentioned
earlier, participants with moderate depressive symptoms were recruited with a widely
used screening measure, the Center for Epidemiological Studies Depression Scale (CESD; Radloff, 1977). Although scores within the “moderate” depression range (i.e., 16-24)
are thought to indicate concern for depressive disorders, the presence of specific
depressive disorders was not thoroughly assessed, and many individuals’ scores had
decreased from the initial screening session to the baseline assessment. Although a
structured interview was used during the phone screening, we did not require that
participants meet criteria for major depressive episodes or dysthymia to be admitted into
the study. The structured interview was only utilized to rule out individuals who reported
the presence of certain diagnoses (e.g., PTSD) or psychological features (e.g.,
suicidality). Future investigations examining the effects of mindfulness training on
depression would benefit from using structured clinical interviews, such as the SCID-I, to
recruit participants meeting criteria for DSM-IV depressive disorders. If using a short

32

screening measure of depression, the Beck Depression Inventory (BDI) may be preferred
to the CES-D because it has been shown to have fewer false positives in regard to
adolescent or young adult samples (Roberts et al., 1991). If the CES-D is utilized,
researchers should consider using higher cut scores when selecting for depressed young
adults (Lawrence et al., 2006).
Second, the current study did not document longitudinal changes in the contactcontrol group due to a requirement by the IRB that mindfulness training should be
offered to control participants the semester following the 6-week post-treatment
assessment (all declined). Future studies should assess both intervention and control
groups at all three time points. This will allow researchers to more thoroughly assess
whether maintained effects are the result of treatment or time.
Finally, the current study did not offer a full-length, empirically supported
mindfulness training program, such MBSR or MBCT, to participants with depressive
symptoms. These programs, which typically include 8 weekly 2-hour sessions, have
been shown to have significant therapeutic effects on symptoms and well-being (e.g.,
Keng et al., 2011) and to reduce the risk of depressive relapse (e.g., Piet & Hougaard). It
is quite possible that additional sessions or treatment components not offered in the
current study may be necessary for cultivating meaningful increases in mindfulness and
emotion regulation and for increasing awareness of emotional and cognitive processes so
that participants can accurately reflect and report on changes that occur over the course of
treatment.
Finally, although the present study included a longer follow-up than is typical for
this literature, an even longer follow-up would have been useful for examining whether
the change in immune variables seen at post-treatment and 3-month follow-up was
associated with protection against future episodes of depressive symptoms.
Conclusion
Despite the lack of condition effects on changes in numerous psychological
variables, the current study showed that only mindfulness training led to improvements in
immune functioning. Specifically, levels of salivary pro-inflammatory cytokines were
reduced at post-treatment in the mindfulness condition, and these effects were maintained
at a 3-month follow-up assessment. This is noteworthy because it demonstrates that even
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short-term training in mindfulness could have important implications for physical and
psychological health. There is some evidence to suggest that higher baseline levels of
pro-inflammatory cytokines in healthy individuals are risk factors for the development of
disorders such as depression (Wichers et al., 2006). Although the directionality of the
inflammation-depression relation is complex (Howren et al., 2009), it could be that
reductions in pro-inflammatory cytokines of the kind seen in the mindfulness condition
are capable of preventing the development of future episodes of depression.

Copyright © Erin Celine Walsh, 2011
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